M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan
โ Scribed by Yoshihiko Oka; Robert A. Waterland; J.Keith Killian; Catherine M. Nolan; Hong-Seok Jang; Keiji Tohara; Seigo Sakaguchi; Tsuneyoshi Yao; Akinori Iwashita; Yutaka Yata; Terumi Takahara; Shin-ichiro Sato; Kazuyuki Suzuki; Tomoyuki Masuda; Randy L. Jirtle
- Book ID
- 111721820
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 370 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and
The mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) suppresses cell growth through binding to the insulin-like growth factor 2 (IGF2) and latent complex of the transforming growth factor-โค (TGF-โค). Recently, it was reported in the United States that loss of heterozygosity (LOH)